Novo Nordisk just killed its deal with Hims & Hers. But Hims might come out stronger after this development. Read why the ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a ...

Just a couple of months after launching a partnership with direct-to-consumer telehealth company Hims & Hers, Novo Nordisk is terminating the collaboration, the company announced on Monday. The ...

Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...

Hims & Hers is also planning to introduce a new, personalized dimension of digital health in Europe. Through this, the company aims to provide individuals with access to care tailored to their ...

HIMS' Price Performance, Valuation and Estimates Shares of Hims & Hers have surged 121.7% year to date compared with the industry ’s gain of 22.9%. Image Source: Zacks Investment Research ...

Hims & Hers Health (HIMS) announced on Tuesday an acquisition of the European digital health platform, ZAVA, as part of the health and wellness company's global expansion drive.

HIMS Percent of Float Short data by YCharts. Per the chart above, roughly 35% of Hims & Hers float is sold short. Investors who short a stock are betting its price will fall.

One healthcare player that is (so far) outmaneuvering investor trepidation throughout 2025 is telemedicine company Hims & Hers Health (HIMS 6.81%). Its share price is up 138% in 2025 (as of June 17).